论文部分内容阅读
Biotrin公司开发新型毒理掩蔽剂Biotrin国际爱尔兰公司正计划开发谷胱甘肽S转移酶(GST),用于掩蔽某些有毒性的药物,这项技术已成功地应用于器官移植病人,以检测器官排斥作用和毒性反应。Biotrin公司开发了一系列测定GST的方法。受损组织...
Biotrin Develops New Toxic Masking Agent Biotrin International Ireland is planning to develop glutathione S-transferase (GST) to mask some of the toxic drugs that have been successfully used in organ transplant patients to detect Organ rejection and toxic reactions. Biotrin has developed a series of methods for determining GST. Damaged tissue ...